FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new radiopharmaceutical compounds of structural formula
.
In formula I, R means H or a (C1-C8)alkyl group; W means a bond, -CH(NH2)-, -C(O)-NH-CH(COOH)-, -O-(CH2)n-O-(CH2)n- or -(CH2)nO(CH2)nO(CH2)n; Z means -NHC(O)-, -NH-C(O)-CH(NH2)- or -C(O)-NH-CH(COOH)-; e is an integer from 1 to 4; f is an integer from 0 to 10; g is an integer from 0 to 10; n is an integer from 0 to 2; the radical NRaRb values are presented in the patent claim.
EFFECT: invention refers to the radionuclide complex containing a radioactive metal and the above compounds, to a pharmaceutical compound for visualising and to a method for visualising any patient's region, e.g. a tissue specified in the spleen tissue, kidney tissue or PSMA-expressing tumour tissue.
21 cl, 6 dwg, 1 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
TECHNETIUM AND RHENIUM COMPLEXES WITH BIS(HETEROARYLS) AND METHODS FOR USING THEM | 2009 |
|
RU2539584C2 |
CA-IX SPECIFIC RADIOPHARMACEUTICAL AGENTS FOR TREATING AND IMAGING MALIGNANT TUMOURS | 2009 |
|
RU2539565C2 |
2-AMINOPYRASINE DERIVATIVES AS CSF-1R KINASE INHIBITORS | 2013 |
|
RU2642777C2 |
4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES | 2007 |
|
RU2463292C2 |
OXOAZETIDINE DERIVATIVES, METHOD FOR PRODUCING AND USING THEREOF IN MEDICINE AND COSMETIC MEDICINE | 2009 |
|
RU2671189C1 |
OXOAZETIDINE DERIVATIVES, METHOD FOR PRODUCING THEM AND USING THEM IN MEDICINE AND COSMETIC MEDICINE | 2009 |
|
RU2569886C2 |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
SUBSTITUTED DIALKYL (OXIDE)-Λ-SULFANILIDENE NICOTINAMIDE DERIVATIVES AS KINASE INHIBITORS | 2014 |
|
RU2711749C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
BENZOIC ACID DERIVATIVES AS PPAR α AND PPAR λ MODULATORS | 2003 |
|
RU2339613C2 |
Authors
Dates
2014-11-20—Published
2009-12-04—Filed